Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 28.83B | 28.27B | 28.47B | 27.33B | 24.86B | 25.63B |
Gross Profit | 9.60B | 8.81B | 9.21B | 8.68B | 8.06B | 8.46B |
EBITDA | 2.12B | 2.68B | 2.30B | 2.63B | 1.97B | 2.15B |
Net Income | 782.95M | 1.33B | 713.57M | 1.17B | 566.22M | 521.80M |
Balance Sheet | ||||||
Total Assets | 28.61B | 26.28B | 26.78B | 26.45B | 25.50B | 25.11B |
Cash, Cash Equivalents and Short-Term Investments | 4.84B | 5.15B | 4.87B | 4.00B | 3.47B | 3.47B |
Total Debt | 3.61B | 4.29B | 4.09B | 5.19B | 6.48B | 6.44B |
Total Liabilities | 11.97B | 9.59B | 11.75B | 12.67B | 13.10B | 13.16B |
Stockholders Equity | 16.64B | 16.69B | 15.03B | 13.79B | 12.41B | 11.95B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 362.29M | 2.18B | 1.98B | 65.57M | 1.34B |
Operating Cash Flow | 0.00 | 516.56M | 2.46B | 2.27B | 437.38M | 1.80B |
Investing Cash Flow | 0.00 | -256.65M | -551.73M | -310.00M | -636.56M | -429.14M |
Financing Cash Flow | 0.00 | -216.60M | -1.42B | -1.56B | -168.16M | -970.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥34.60B | 8.89 | 5.14% | 12.38% | 68.86% | ||
71 Outperform | ¥7.14B | 5.40 | 1.63% | -0.72% | 86.46% | ||
71 Outperform | ¥7.36B | 17.29 | 3.33% | -0.51% | 420.31% | ||
66 Neutral | ¥15.07B | 20.71 | 4.21% | -9.21% | -68.22% | ||
63 Neutral | $33.92B | 6.00 | -11.84% | 1.85% | 5.31% | -18.34% | |
60 Neutral | ¥2.91B | 72.82 | 4.53% | -1.04% | -163.70% | ||
58 Neutral | ¥1.98B | ― | ― | -4.72% | -400.98% |